# ENDRA Life Sciences Inc.: filings

NDRA · Nasdaq · CIK 1681682 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ndra.md) · [Financials](/companies/ndra/financials.md) · [Filings](/companies/ndra/filings.md) · [Insiders](/companies/ndra/insiders.md)

## Reports and events: 194 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 146, 8-K 115, 10-Q 29, CORRESP 25, 425 19, S-1/A 17, 424B5 16, DEFA14A 14, 3 13, UPLOAD 12, DEF 14A 11, EFFECT 11, 10-K 9, S-8 9, S-3 8, 424B3 7, 4/A 7, PRE 14A 7, SC 13G 6, 3/A 4, 8-A12B/A 4, D 4, S-1 4, 8-K/A 3, ARS 3, S-3/A 3, SCHEDULE 13G/A 3, 10-K/A 2, 25-NSE 2, CERTNAS 2, DRS 2, POS AM 2, S-1MEF 2, SCHEDULE 13D 2, SCHEDULE 13G 2, 10-Q/A 1, 144 1, 424B1 1, 424B4 1, 424B7 1, 8-A12B 1, 8-A12G 1, CERTNYS 1, DRS/A 1, DRSLTR 1, NT 10-Q 1, RW 1, S-4 1, SC 13G/A 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 16:15 ET | [SCHEDULE 13D](/filings/0001477932-26-006128.md) | Ownership report, active investor | 0001477932-26-006128 |
| 2026-10-01 | 17:18 ET | [8-K](/filings/0001213900-26-105899.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-105899 |
| 2026-08-17 | 16:05 ET | [8-K](/filings/0001213900-26-090747.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090747 |
| 2026-08-14 | 16:05 ET | [10-Q](/filings/0001213900-26-090027.md) | Quarterly report, period 2026-06-30 | 0001213900-26-090027 |
| 2026-07-09 | 06:08 ET | [8-K](/filings/0001213900-26-076526.md) | 8.01 Other events | 0001213900-26-076526 |
| 2026-06-29 | 21:29 ET | [SCHEDULE 13D/A](/filings/0001213900-26-073318.md) | Ownership report, active investor, amended | 0001213900-26-073318 |
| 2026-06-26 | 06:10 ET | [8-K](/filings/0001213900-26-072268.md) | 1.01 Entry into a material agreement; 5.01 Change in control; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-072268 |
| 2026-06-25 | 09:37 ET | [8-K](/filings/0001213900-26-071804.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-071804 |
| 2026-05-28 | 06:07 ET | [8-K](/filings/0001213900-26-061701.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-061701 |
| 2026-05-15 | 16:01 ET | [10-Q](/filings/0001213900-26-057680.md) | Quarterly report, period 2026-03-31 | 0001213900-26-057680 |
| 2026-04-21 | 08:00 ET | [8-K](/filings/0001213900-26-045885.md) | 3.01 Delisting notice | 0001213900-26-045885 |
| 2026-03-31 | 17:10 ET | [10-K](/filings/0001213900-26-037617.md) | Annual report, period 2025-12-31 | 0001213900-26-037617 |
| 2026-03-31 | 16:29 ET | [8-K](/filings/0001213900-26-037497.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-037497 |
| 2026-03-25 | 09:21 ET | [8-K](/filings/0001213900-26-033878.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-033878 |
| 2025-12-15 | 20:31 ET | [8-K](/filings/0001213900-25-121374.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-121374 |
| 2025-11-28 | 16:23 ET | [8-K](/filings/0001213900-25-116103.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-116103 |
| 2025-11-26 | 16:30 ET | [SCHEDULE 13D](/filings/0000898432-25-000936.md) | Ownership report, active investor | 0000898432-25-000936 |
| 2025-11-14 | 16:27 ET | [8-K](/filings/0001213900-25-110897.md) | 8.01 Other events | 0001213900-25-110897 |
| 2025-11-14 | 16:24 ET | [10-Q](/filings/0001213900-25-110887.md) | Quarterly report, period 2025-09-30 | 0001213900-25-110887 |
| 2025-10-30 | 21:15 ET | [8-K](/filings/0001213900-25-103707.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-103707 |
| 2025-10-28 | 07:01 ET | [DEF 14A](/filings/0001654954-25-012254.md) | Proxy statement, period 2024-12-31 | 0001654954-25-012254 |
| 2025-10-23 | 08:10 ET | [8-K](/filings/0001654954-25-012084.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-012084 |
| 2025-10-15 | 17:01 ET | [8-K/A](/filings/0001654954-25-011825.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.08 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-011825 |
| 2025-10-15 | 09:09 ET | [8-K](/filings/0001654954-25-011797.md) | 9.01 Financial statements and exhibits | 0001654954-25-011797 |
| 2025-08-14 | 16:11 ET | [10-Q](/filings/0001654954-25-009643.md) | Quarterly report, period 2025-06-30 | 0001654954-25-009643 |
| 2025-07-25 | 09:28 ET | [S-1/A](/filings/0001654954-25-008477.md) | Registration statement, amended | 0001654954-25-008477 |
| 2025-07-23 | 09:05 ET | [8-K](/filings/0001654954-25-008318.md) | 8.01 Other events | 0001654954-25-008318 |
| 2025-07-16 | 09:05 ET | [S-1/A](/filings/0001654954-25-008117.md) | Registration statement, amended | 0001654954-25-008117 |
| 2025-07-09 | 16:51 ET | [8-K](/filings/0001654954-25-007893.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-007893 |
| 2025-07-09 | 08:56 ET | [S-1](/filings/0001654954-25-007870.md) | Registration statement | 0001654954-25-007870 |
| 2025-06-11 | 08:20 ET | [8-K](/filings/0001654954-25-006811.md) | 7.01 Regulation FD disclosure | 0001654954-25-006811 |
| 2025-05-30 | 08:00 ET | [8-K](/filings/0001654954-25-006282.md) | 3.01 Delisting notice | 0001654954-25-006282 |
| 2025-05-15 | 16:59 ET | [10-Q](/filings/0001654954-25-005770.md) | Quarterly report, period 2025-03-31 | 0001654954-25-005770 |
| 2025-05-15 | 16:58 ET | [8-K](/filings/0001654954-25-005768.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-005768 |
| 2025-04-07 | 18:42 ET | [10-K/A](/filings/0001654954-25-003937.md) | Annual report, amended, period 2024-12-31 | 0001654954-25-003937 |
| 2025-03-31 | 08:51 ET | [10-K](/filings/0001654954-25-003612.md) | Annual report, period 2024-12-31 | 0001654954-25-003612 |
| 2025-03-31 | 08:49 ET | [8-K](/filings/0001654954-25-003611.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-003611 |
| 2024-11-22 | 08:42 ET | [8-K](/filings/0001654954-24-014793.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-014793 |
| 2024-11-21 | 17:14 ET | [10-Q/A](/filings/0001654954-24-014771.md) | Quarterly report, amended, period 2024-09-30 | 0001654954-24-014771 |
| 2024-11-19 | 17:14 ET | [10-Q](/filings/0001654954-24-014670.md) | Quarterly report, period 2024-09-30 | 0001654954-24-014670 |
| 2024-11-15 | 16:06 ET | [8-K](/filings/0001654954-24-014547.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-014547 |
| 2024-11-05 | 08:00 ET | [8-K](/filings/0001654954-24-013720.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001654954-24-013720 |
| 2024-10-29 | 16:05 ET | [8-K](/filings/0001654954-24-013446.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001654954-24-013446 |
| 2024-09-16 | 17:28 ET | [DEF 14A](/filings/0001654954-24-011972.md) | Proxy statement, period 2024-09-06 | 0001654954-24-011972 |
| 2024-08-28 | 17:09 ET | [8-K](/filings/0001654954-24-011213.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-011213 |
| 2024-08-23 | 16:06 ET | [8-K](/filings/0001654954-24-011072.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-011072 |
| 2024-08-16 | 16:10 ET | [8-K](/filings/0001654954-24-010837.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-010837 |
| 2024-08-14 | 16:06 ET | [10-Q](/filings/0001654954-24-010642.md) | Quarterly report, period 2024-06-30 | 0001654954-24-010642 |
| 2024-08-13 | 09:24 ET | [8-K](/filings/0001654954-24-010399.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-010399 |
| 2024-08-09 | 08:02 ET | [8-K](/filings/0001654954-24-010213.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-010213 |

Page 1 of 4. [Older](/companies/ndra/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:17 ET. No prices; not investment advice.